$0.042 0.0 0.0%
Last Trade - 04/03/21
| Market Cap | £749k |
| Enterprise Value | £2.07m |
| Revenue | £n/a |
| Position in Universe | th / 6651 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005E | 2006E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 1.31 | 0.23 | 0.000 | 0.000 | 0.000 | -100.0% | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Refocus Group, Inc. is a medical device company. The Company is engaged in the research and development of treatments for human vision disorders. The Company's VisAbility is a medical device, which is designed to improve near vision that is performed in both eyes. The Company's treatment for presbyopia can restore the natural ability to focus at near and intermediate distances, without considering the distance vision. The Company's VisAbility Micro-Inserts are precision-molded from a clear plastic material. The Company's VisAbility Procedure is a minimally invasive outpatient procedure, which typically takes 15 to 20 minutes per eye. The Company's VisAbility Procedure consists of inserting four tiny implants in the white part of the eye, referred as the sclera. These implants open the space where the focusing muscles are located, referred as the circumlental space (CLS).
| Last Annual | December 31st, 2004 |
| Last Interim | September 30th, 2005 |
| Incorporated | January 14, 2003 |
| Public Since | March 7, 2003 |
| No. of Shareholders: | 384 |
| No. of Employees: | 4 |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Index | |
| Exchange | Pink Sheets on Nasdaq |
| Shares in Issue | 24,669,105 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 10210 N Central Expy Ste 400, DALLAS, 75231-3471, United States |
| Web | http://www.refocus-group.com/ |
| Phone | +1 214 3680200 |
| Contact | Zack Thompson (Chief Financial Officer, Senior Vice President of Business Development) |
| Auditors | Deloitte & Touche LLP |
As of 04/03/21, shares in Refocus Inc are trading at $0.042, giving the company a market capitalisation of £749k. This share price information is delayed by 15 minutes.
Shares in Refocus Inc are currently trading at $0.042 and the price has moved by -44% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Refocus Inc price has moved by -56.3% over the past year.
There are no analysts currently covering Refocus Inc.
Refocus Inc is scheduled to issue upcoming financial results on the following dates:
Refocus Inc does not currently pay a dividend.
Refocus Inc does not currently pay a dividend.
Refocus Inc does not currently pay a dividend.
To buy shares in Refocus Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Refocus Inc are currently trading at $0.042, giving the company a market capitalisation of £749k.
Here are the trading details for Refocus Inc:
We were not able to load our ranking data for Refocus Inc
We were not able to load any forecast data for Refocus Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Refocus Inc. Over the past six months, the relative strength of its shares against the market has been -61.66%. At the current price of $0.042, shares in Refocus Inc are trading at -40.79% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Refocus Inc.
Refocus Inc's management team is headed by:
Here are the top five shareholders of Refocus Inc based on the size of their shareholding:
